{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T05:29:07Z","timestamp":1794115747262,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the long-term impact of social determinants of health on diabetic retinopathy (DR) incidence, complications, and management in patients with type 2 diabetes mellitus (T2DM), with emphasis on disparities among treatment-adherent individuals and demographic subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using TriNetX, a national electronic health records network spanning 70 U.S. healthcare organisations. Adults diagnosed with T2DM were categorised into socially deprived and non-deprived cohorts based on ICD-10 codes related to housing instability, food insecurity, and financial hardship. Propensity score matching balanced cohorts on demographics, comorbidities, laboratory values, medications, and ophthalmic care utilisation. Outcomes included incident DR, sight-threatening complications, ophthalmic treatment and diagnostics, and documented treatment nonadherence. Cox proportional hazards models estimated hazard ratios (HRs) with 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Matched cohorts included 62,786 socially deprived and 62,786 non-deprived patients (mean age, 54 years; 42% female; 49% White, 27% Black, 14% Hispanic). Over a 10-year follow-up, social deprivation was associated with increased risk of DR (HR 1.40, 95% CI 1.34\u20131.47) and sight-threatening complications, including blindness. Documented nonadherence was significantly increased in the socially deprived cohort (HR 3.57, 95% CI 3.47\u20133.68). Among patients without documented nonadherence, social deprivation was associated with increased DR risk (HR 1.44, 95% CI 1.35\u20131.54) and treatment utilisation. Disparities were most pronounced in males, Hispanic individuals, and adults aged 18\u201339.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Social deprivation, regardless of documented treatment adherence, increased DR incidence and complications. Targeted interventions are needed to address persistent disparities and reduce DR burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-025-04071-y","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:58:03Z","timestamp":1759899483000},"page":"3269-3277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Persistent disparities in diabetic retinopathy outcomes among socially deprived individuals despite treatment adherence"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-6391","authenticated-orcid":false,"given":"Alexander T.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Chwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Humayun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5270-2800","authenticated-orcid":false,"given":"Hossein","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","volume":"141","author":"EA Lundeen","year":"2023","unstructured":"Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141:747\u201354. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2289.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR2","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2021","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators. Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e144\u201360. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7.","journal-title":"Lancet Glob Health"},{"key":"4071_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","volume":"136","author":"JG Gross","year":"2018","unstructured":"Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, et al. Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136:1138\u201348. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3255.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR4","doi-asserted-by":"publisher","first-page":"e19236","DOI":"10.1097\/MD.0000000000019236","volume":"99","author":"L Yin","year":"2020","unstructured":"Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients. Med (Balt). 2020;99:e19236. https:\/\/doi.org\/10.1097\/MD.0000000000019236.","journal-title":"Med (Balt)"},{"key":"4071_CR5","doi-asserted-by":"publisher","first-page":"e0269231","DOI":"10.1371\/journal.pone.0269231","volume":"17","author":"AX Chan","year":"2022","unstructured":"Chan AX, McDermott Iv JJ, Lee TC, Ye GY, Shahrvini B, Radha Saseendrakumar B, et al. Associations between healthcare utilization and access and diabetic retinopathy complications using All of Us nationwide survey data. PLoS One. 2022;17:e0269231. https:\/\/doi.org\/10.1371\/journal.pone.0269231.","journal-title":"PLoS One"},{"key":"4071_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/bjophthalmol-2018-312568","volume":"103","author":"AK Denniston","year":"2019","unstructured":"Denniston AK, Lee AY, Lee CS, Crabb DP, Bailey C, Lip PL, et al. United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services. Br J Ophthalmol. 2019;103:837\u201343. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312568.","journal-title":"Br J Ophthalmol"},{"key":"4071_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2337\/dc23-1626","volume":"47","author":"L Tan","year":"2024","unstructured":"Tan L, Wang J, Han J, Sainsbury C, Denniston AK, Crowe FL, et al. Socioeconomic deprivation and the risk of sight-threatening diabetic retinopathy: a population-based cohort study in the U.K. Diab Care. 2024;47:844\u20138. https:\/\/doi.org\/10.2337\/dc23-1626.","journal-title":"Diab Care"},{"key":"4071_CR8","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaophthalmol.2024.3528","volume":"142","author":"AS Chaudhury","year":"2024","unstructured":"Chaudhury AS, Ige M, Marwah S, Zhou X, Andrews CA, Kanwar K, et al. Race, social determinants of health, and the quality of diabetic eye care. JAMA Ophthalmol. 2024;142:961\u201370. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.3528.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/jamaophthalmol.2023.5287","volume":"141","author":"R Ravindranath","year":"2023","unstructured":"Ravindranath R, Bernstein IA, Fernandez KS, Ludwig CA, Wang SY. Social determinants of health and perceived barriers to care in diabetic retinopathy screening. JAMA Ophthalmol. 2023;141:1161\u201371. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.5287.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajo.2024.07.028","volume":"268","author":"M Rahmati","year":"2024","unstructured":"Rahmati M, Smith L, Boyer L, Fond G, Yon DK, Lee H, et al. Factors affecting global adherence for the uptake of diabetic retinopathy screening: a systematic review and meta-analysis. Am J Ophthalmol. 2024;268:94\u2013107. https:\/\/doi.org\/10.1016\/j.ajo.2024.07.028.","journal-title":"Am J Ophthalmol"},{"key":"4071_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ophtha.2023.06.007","volume":"130","author":"C Taccheri","year":"2023","unstructured":"Taccheri C, Jordan J, Tran D, Wang J, Han D, Varadaraj V, et al. The impact of social determinants of health on eye care utilization in a national sample of people with diabetes. Ophthalmology. 2023;130:1037\u201345. https:\/\/doi.org\/10.1016\/j.ophtha.2023.06.007.","journal-title":"Ophthalmology"},{"key":"4071_CR12","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.3390\/jcm11237120","volume":"11","author":"D Patel","year":"2022","unstructured":"Patel D, Ananthakrishnan A, Lin T, Channa R, Liu TYA, Wolf RM. Social determinants of health and impact on screening, prevalence, and management of diabetic retinopathy in adults: a narrative review. J Clin Med. 2022;11:7120. https:\/\/doi.org\/10.3390\/jcm11237120.","journal-title":"J Clin Med"},{"key":"4071_CR13","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.ophtha.2019.05.033","volume":"126","author":"SE Eppley","year":"2019","unstructured":"Eppley SE, Mansberger SL, Ramanathan S, Lowry EA. Characteristics associated with adherence to annual dilated eye examinations among US patients with diagnosed diabetes. Ophthalmology. 2019;126:1492\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2019.05.033.","journal-title":"Ophthalmology"},{"key":"4071_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6:ooad035. https:\/\/doi.org\/10.1093\/jamiaopen\/ooad035.","journal-title":"JAMIA Open"},{"key":"4071_CR15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806\u20138. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD.","journal-title":"BMJ"},{"key":"4071_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/qjmed\/hcad275","volume":"117","author":"AH Simoni","year":"2023","unstructured":"Simoni AH, Bucci T, Romiti GF, Frydenlund J, Johnsen SP, Abdul-Rahim AH, et al. Social determinants of health and clinical outcomes among patients with atrial fibrillation: evidence from a global federated health research network. QJM: Int J Med. 2023;117:353\u20139. https:\/\/doi.org\/10.1093\/qjmed\/hcad275.","journal-title":"QJM: Int J Med"},{"key":"4071_CR17","doi-asserted-by":"publisher","first-page":"e2312538","DOI":"10.1001\/jamanetworkopen.2023.12538","volume":"6","author":"AR Agarwal","year":"2023","unstructured":"Agarwal AR, Prichett L, Jain A, Srikumaran U. Assessment of Use of ICD-9 and ICD-10 codes for social determinants of health in the US, 2011\u20132021. JAMA Netw Open. 2023;6:e2312538. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.12538.","journal-title":"JAMA Netw Open"},{"key":"4071_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.18553\/jmcp.2021.27.4.497","volume":"27","author":"J Gatwood","year":"2021","unstructured":"Gatwood J, Hohmeier KC, Shuvo S, Mikaiel D, Kovesdy CP. Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension. J Manag Care Spec Pharm. 2021;27:497\u2013506. https:\/\/doi.org\/10.18553\/jmcp.2021.27.4.497.","journal-title":"J Manag Care Spec Pharm"},{"key":"4071_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jcjd.2021.01.014","volume":"45","author":"O Egunsola","year":"2021","unstructured":"Egunsola O, Dowsett LE, Diaz R, Brent MH, Rac V, Clement FM. Diabetic retinopathy screening: a systematic review of qualitative literature. Can J Diab. 2021;45:725\u201333.e12. https:\/\/doi.org\/10.1016\/j.jcjd.2021.01.014.","journal-title":"Can J Diab"},{"key":"4071_CR20","doi-asserted-by":"publisher","first-page":"e0291280","DOI":"10.1371\/journal.pone.0291280","volume":"19","author":"M Zhao","year":"2024","unstructured":"Zhao M, Chandra A, Liu L, Zhang L, Xu J, Li J. Investigation of the reasons for delayed presentation in proliferative diabetic retinopathy patients. PLoS One. 2024;19:e0291280 https:\/\/doi.org\/10.1371\/journal.pone.0291280.","journal-title":"PLoS One"},{"key":"4071_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14425","volume":"38","author":"JG Lawrenson","year":"2021","unstructured":"Lawrenson JG, Bourmpaki E, Bunce C, Stratton IM, Gardner P, Anderson J, et al. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort. Diabet Med. 2021;38:e14425. https:\/\/doi.org\/10.1111\/dme.14425.","journal-title":"Diabet Med"},{"key":"4071_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2147\/OPTH.S73272","volume":"9","author":"M Lane","year":"2015","unstructured":"Lane M, Mathewson PA, Sharma HE, Palmer H, Shah P, Nightingale P, et al. Social deprivation as a risk factor for late presentation of proliferative diabetic retinopathy. Clin Ophthalmol. 2015;9:347\u201352. https:\/\/doi.org\/10.2147\/OPTH.S73272.","journal-title":"Clin Ophthalmol"},{"key":"4071_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jama.1993.03500100088034","volume":"269","author":"FL Ferris","year":"1993","unstructured":"Ferris FL. How effective are treatments for diabetic retinopathy?. JAMA. 1993;269:1290\u20131.","journal-title":"JAMA"},{"key":"4071_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3928\/23258160-20211018-01","volume":"52","author":"NA Malhotra","year":"2021","unstructured":"Malhotra NA, Muste J, Hom GL, Conti TF, Greenlee TE, Singh RP. Race and socioeconomic status in anti-VEGF treatment of diabetic macular edema. Ophthalmic Surg Lasers Imaging Retin. 2021;52:578\u201385. https:\/\/doi.org\/10.3928\/23258160-20211018-01.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"4071_CR25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamaophthalmol.2018.0813","volume":"136","author":"YH Lee","year":"2018","unstructured":"Lee YH, Chen AX, Varadaraj V, Hong GH, Chen Y, Friedman DS, et al. Comparison of access to eye care appointments between patients with medicaid and those with private health care insurance. JAMA Ophthalmol. 2018;136:622\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.0813.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR26","first-page":"e297","volume":"21","author":"E Hatef","year":"2015","unstructured":"Hatef E, Vanderver BG, Fagan P, Albert M, Alexander M. Annual diabetic eye examinations in a managed care Medicaid population. Am J Manag Care. 2015;21:e297\u2013302.","journal-title":"Am J Manag Care"},{"key":"4071_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/jamaophthalmol.2024.0046","volume":"142","author":"J Markle","year":"2024","unstructured":"Markle J, Shaia JK, Araich H, Sharma N, Talcott KE, Singh RP. Longitudinal trends and disparities in diabetic retinopathy within an aggregate health care network. JAMA Ophthalmol. 2024;142:599\u2013606. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.0046.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR28","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2337\/dc13-1038","volume":"37","author":"Q Shi","year":"2014","unstructured":"Shi Q, Zhao Y, Fonseca V, Krousel-Wood M, Shi L. Racial disparity of eye examinations among the U.S. working-age population with diabetes: 2002\u20132009. Diab Care. 2014;37:1321\u20138. https:\/\/doi.org\/10.2337\/dc13-1038.","journal-title":"Diab Care"},{"key":"4071_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ijerph15010157","volume":"15","author":"RM Kashim","year":"2018","unstructured":"Kashim RM, Newton P, Ojo O. Diabetic retinopathy screening: a systematic review on patients\u2019 non-attendance. Int J Environ Res Public Health. 2018;15:157 https:\/\/doi.org\/10.3390\/ijerph15010157.","journal-title":"Int J Environ Res Public Health"},{"key":"4071_CR30","doi-asserted-by":"publisher","first-page":"5814296","DOI":"10.1155\/2020\/5814296","volume":"2020","author":"M Li","year":"2020","unstructured":"Li M, Wang Y, Liu Z, Tang X, Mu P, Tan Y, et al. Females with type 2 diabetes mellitus are prone to diabetic retinopathy: a twelve-province cross-sectional study in China. J Diab Res. 2020;2020:5814296. https:\/\/doi.org\/10.1155\/2020\/5814296.","journal-title":"J Diab Res"},{"key":"4071_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diab Care. 2012;35:556\u201364. https:\/\/doi.org\/10.2337\/dc11-1909.","journal-title":"Diab Care"},{"key":"4071_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1258\/096914106778440608","volume":"13","author":"C Millett","year":"2006","unstructured":"Millett C, Dodhia H. Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. J Med Screen. 2006;13:152\u20135. https:\/\/doi.org\/10.1258\/096914106778440608.","journal-title":"J Med Screen"},{"key":"4071_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1464-5491.2010.02946.x","volume":"27","author":"MC Gulliford","year":"2010","unstructured":"Gulliford MC, Dodhia H, Chamley M, McCormick K, Mohamed M, Naithani S, et al. Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med. 2010;27:282\u20138. https:\/\/doi.org\/10.1111\/j.1464-5491.2010.02946.x.","journal-title":"Diabet Med"},{"key":"4071_CR34","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2337\/dc21-1072","volume":"45","author":"TODAY Study Group","year":"2021","unstructured":"TODAY Study Group. Development and progression of diabetic retinopathy in adolescents and young adults with type 2 diabetes: results from the TODAY study. Diab Care. 2021;45:1049\u201355. https:\/\/doi.org\/10.2337\/dc21-1072.","journal-title":"Diab Care"},{"key":"4071_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2021.09.010","volume":"129","author":"DB Rein","year":"2022","unstructured":"Rein DB, Wittenborn JS, Zhang P, Sublett F, Lamuda PA, Lundeen EA, et al. The economic burden of vision loss and blindness in the United States. Ophthalmology. 2022;129:369\u201378. https:\/\/doi.org\/10.1016\/j.ophtha.2021.09.010.","journal-title":"Ophthalmology"},{"key":"4071_CR36","doi-asserted-by":"publisher","first-page":"e042484","DOI":"10.1136\/bmjopen-2020-042484","volume":"10","author":"HL Jeon","year":"2020","unstructured":"Jeon HL, Lee H, Yoon D, Lee Y, Kim JH, Jee D, et al. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis. BMJ Open. 2020;10:e042484. https:\/\/doi.org\/10.1136\/bmjopen-2020-042484.","journal-title":"BMJ Open"},{"key":"4071_CR37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jamaophthalmol.2017.2553","volume":"135","author":"JR Willis","year":"2017","unstructured":"Willis JR, Doan QV, Gleeson M, Haskova Z, Ramulu P, Morse L, et al. Vision-related functional burden of diabetic retinopathy across severity levels in the United States. JAMA Ophthalmol. 2017;135:926\u201332. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.2553.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1442-9071.2011.02599.x","volume":"40","author":"E Fenwick","year":"2012","unstructured":"Fenwick E, Rees G, Pesudovs K, Dirani M, Kawasaki R, Wong TY, et al. Social and emotional impact of diabetic retinopathy: a review. Clin Exp Ophthalmol. 2012;40:27\u201338. https:\/\/doi.org\/10.1111\/j.1442-9071.2011.02599.x.","journal-title":"Clin Exp Ophthalmol"},{"key":"4071_CR39","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/jamaophthalmol.2022.4566","volume":"140","author":"S Besagar","year":"2022","unstructured":"Besagar S, Yonekawa Y, Sridhar J, Finn A, Padovani-Claudio DA, Sternberg P Jr, et al. Association of socioeconomic, demographic, and health care access disparities with severe visual impairment in the US. JAMA Ophthalmol. 2022;140:1219\u201326. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4566.","journal-title":"JAMA Ophthalmol"},{"key":"4071_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03665-6","volume":"24","author":"M Benhamza","year":"2024","unstructured":"Benhamza M, Dahlui M, Said MA. Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review. BMC Ophthalmol. 2024;24:424. https:\/\/doi.org\/10.1186\/s12886-024-03665-6.","journal-title":"BMC Ophthalmol"},{"key":"4071_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MLR.0000000000001800","volume":"61","author":"D Gupta","year":"2023","unstructured":"Gupta D, Self S, Thomas D, Supra J, Rudisill C. Understanding the role of a technology and EMR-based social determinants of health screening tool and community-based resource connections in health care resource utilization. Med Care. 2023;61:423\u201330. https:\/\/doi.org\/10.1097\/MLR.0000000000001800.","journal-title":"Med Care"},{"key":"4071_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamainternmed.2017.0204","volume":"177","author":"LP Daskivich","year":"2017","unstructured":"Daskivich LP, Vasquez C, Martinez C, Tseng CH, Mangione CM. Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles county department of health services. JAMA Intern Med. 2017;177:642\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2017.0204.","journal-title":"JAMA Intern Med"},{"key":"4071_CR43","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1097\/MLR.0000000000001029","volume":"57","author":"P Buitron de la Vega","year":"2019","unstructured":"Buitron de la Vega P, Losi S, Sprague Martinez L, Bovell-Ammon A, Garg A, James T, et al. Implementing an EHR-based screening and referral system to address social determinants of health in primary care. Med Care. 2019;57:S133\u20139. https:\/\/doi.org\/10.1097\/MLR.0000000000001029.","journal-title":"Med Care"},{"key":"4071_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.7326\/0003-4819-139-11-200312020-00009","volume":"139","author":"LA Cooper","year":"2003","unstructured":"Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med. 2003;139:907\u201315. https:\/\/doi.org\/10.7326\/0003-4819-139-11-200312020-00009.","journal-title":"Ann Intern Med"},{"key":"4071_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/wvn.12176","volume":"13","author":"L Govere","year":"2016","unstructured":"Govere L, Govere EM. How effective is cultural competence training of healthcare providers on improving patient satisfaction of minority groups? a systematic review of literature. Worldviews Evid Based Nurs. 2016;13:402\u201310. https:\/\/doi.org\/10.1111\/wvn.12176.","journal-title":"Worldviews Evid Based Nurs"},{"key":"4071_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.optom.2019.12.004","volume":"13","author":"D Kalogeropoulos","year":"2020","unstructured":"Kalogeropoulos D, Kalogeropoulos C, Stefaniotou M, Neofytou M. The role of tele-ophthalmology in diabetic retinopathy screening. J Optom. 2020;13:262\u20138. https:\/\/doi.org\/10.1016\/j.optom.2019.12.004.","journal-title":"J Optom"},{"key":"4071_CR47","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2337\/dc20-1671","volume":"44","author":"RM Wolf","year":"2021","unstructured":"Wolf RM, Liu TYA, Thomas C, Prichett L, Zimmer-Galler I, Smith K, et al. The SEE study: safety, efficacy, and equity of implementing autonomous artificial intelligence for diagnosing diabetic retinopathy in youth. Diab Care. 2021;44:781\u20137. https:\/\/doi.org\/10.2337\/dc20-1671.","journal-title":"Diab Care"},{"key":"4071_CR48","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/MLR.0000000000001418","volume":"58","author":"HP Truong","year":"2020","unstructured":"Truong HP, Luke AA, Hammond G, Wadhera RK, Reidhead M, Maddox KEJ. Utilization of social determinants of health ICD-10 Z-codes among hospitalized patients in the United States, 2016\u20132017. Med Care. 2020;58:1037\u201343. https:\/\/doi.org\/10.1097\/MLR.0000000000001418.","journal-title":"Med Care"},{"key":"4071_CR49","doi-asserted-by":"publisher","first-page":"e23818","DOI":"10.1097\/MD.0000000000023818","volume":"99","author":"Y Guo","year":"2020","unstructured":"Guo Y, Chen Z, Xu K, George TJ, Wu Y, Hogan W, et al. International classification of diseases, tenth revision, clinical modification social determinants of health codes are poorly used in electronic health records. Med (Balt). 2020;99:e23818. https:\/\/doi.org\/10.1097\/MD.0000000000023818.","journal-title":"Med (Balt)"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04071-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:39:35Z","timestamp":1764599975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04071-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":49,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04071-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}